Nutritional biomarker score of the Mediterranean diet: study-specific distribution by the MedLey trial arms post-intervention and the EPIC-InterAct subcohort by country at baseline.
Cancer
CANCER
 The biomarker score was derived as a discriminatory model between the Mediterranean and habitual diet in the MedLey randomised partial-feeding controlled trial. Circulating carotenoids and fatty acids were used to calculate the score as linear predictions from the discriminatory model. The score was standardised separately within the MedLey trial and the EPIC-InterAct subcohort. Boxes denote the IQR and medians inside; and whiskers, values up to 1.5 IQR outside of these percentiles. EPIC, European Prospective Investigation into Cancer and Nutrition; IQR, interquartile range; UK, United Kingdom.